MARLBOROUGH, Mass.--(BUSINESS WIRE)--Xcellerex, Inc., a supplier of innovative manufacturing technologies for the fast-growing biopharmaceutical industry, has introduced its XDR™-10 single-use ...
Xcellerex will leverage its XDR bioreactors and FlexFactory platform to allow future scale-up. Xcellerex and Humacyte signed a collaboration agreement under which Xcellerex will develop a single-use ...
Partnership will enable rapid, cost-effective, production of novel Humacyte vascular grafts for transplantation utilizing Xcellerex's XDR single-use technologies MARLBOROUGH, Mass. & RESEARCH TRIANGLE ...
Xcellerex, Inc. announced today that it has raised $31 million in a Series C financing to advance the development and commercialization of its proprietary FlexFactory(TM) manufacturing system and ...
Disposable bioprocessing technology is taking a step forward in a deal between platform- and service-provider Xcellerex and extracellular matrix tissue-maker Humacyte. Xcellerex will scale up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback